Advertisement
Virax Biolabs Group Limited (VRAX)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Follow
At close: 04:00PM EST
After hours:
| Previous Close | 1.9400 |
| Open | 1.9600 |
| Bid | 1.9800 x 200 |
| Ask | 2.0800 x 100 |
| Day's Range | 1.9100 - 2.1000 |
| 52 Week Range | 0.6000 - 9.0000 |
| Volume | |
| Avg. Volume | 3,374,129 |
| Market Cap | 8.727M |
| Beta (5Y Monthly) | 1.92 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.3600 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PR NewswireVirax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland
Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, today announced that it has entered into a distribution agreement with Europa Biosite to commercialize the company's ImmuneSelect Research Use portfolio in the United Kingdom and Ireland through its wholly owned subsidiary Cambridge Bioscience.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.